데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
30766-22-4COC(=O)c1cncc(O)c1KJJSHOHQQHACLE-UHFFFAOYSA-N30766-22-4DTXSID30326624CHEMBL1700220Light beige powder and lumps
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Danger
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 43 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
용도Methyl 5-Hydroxynicotinate is an intermediate used to prepare selective cyclooxygenase-2 inhibitors. It is also used to prepare imino sugars as inhibitors of liver glycogen phosphorylase.
The synthesis method of Methyl 5-hydroxynicotinate is as follows: 5-Hydroxynicotinic acid was dissolved in methanol, sulfuric acid was added, and the mixture was stirred at 70°C for 12 hours under nitrogen protection. After the reaction solution was concentrated, the residue was dissolved in dichloromethane, and the pH of the system was adjusted to 8 with saturated sodium bicarbonate solution. A white solid slowly precipitated out, and the mixture was filtered to obtain the final product.